Product Code: ETC6188453 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Plasma therapy in Australia includes treatments such as platelet-rich plasma (PRP) for wound healing, orthopedic conditions, and cosmetic applications. Increasing acceptance among clinicians, advancements in plasma preparation technologies, and growing patient demand for minimally invasive therapies contribute to the expansion of this market.
Plasma Therapy is gaining traction in Australia, driven by its expanding applications in regenerative medicine, wound healing, and orthopedics. Rising clinical research supporting efficacy and safety, coupled with growing patient preference for minimally invasive therapies, are key factors propelling the market. The COVID-19 pandemic also heightened interest in convalescent plasma therapies.
The plasma therapy market grapples with limited clinical evidence for some indications, causing hesitance among healthcare providers. Regulatory barriers and reimbursement issues affect treatment adoption. Additionally, high costs and limited availability of plasma-derived products constrain wider use.
The plasma therapy market in Australia is expanding due to rising applications in regenerative medicine, wound healing, and cosmetic procedures. The adoption of platelet-rich plasma (PRP) and other plasma-based therapies is growing among medical professionals, driving demand for advanced treatment devices and consumables. Investment in clinical research and commercialization of novel plasma therapies can leverage the increasing acceptance of minimally invasive treatment options.
Australias healthcare policies support plasma therapy by integrating it within regulated treatment frameworks overseen by the TGA and health departments. The government promotes clinical research, patient access programs, and safety monitoring. Policies also emphasize ethical sourcing of plasma and transparency in therapy efficacy.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Plasma Therapy Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Plasma Therapy Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Plasma Therapy Market - Industry Life Cycle |
3.4 Australia Plasma Therapy Market - Porter's Five Forces |
3.5 Australia Plasma Therapy Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Plasma Therapy Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Australia Plasma Therapy Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Australia Plasma Therapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases such as cancer and autoimmune disorders driving demand for plasma therapy |
4.2.2 Technological advancements in plasma collection and processing techniques improving efficiency and efficacy of treatments |
4.2.3 Growing awareness about the benefits of plasma therapy among healthcare professionals and patients |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for plasma collection and processing impacting market growth |
4.3.2 Limited availability of skilled healthcare professionals trained in administering plasma therapy |
4.3.3 High cost associated with plasma therapy treatments limiting adoption rates |
5 Australia Plasma Therapy Market Trends |
6 Australia Plasma Therapy Market, By Types |
6.1 Australia Plasma Therapy Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Plasma Therapy Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Australia Plasma Therapy Market Revenues & Volume, By Pure Platelet-rich plasma (PRP), 2021- 2031F |
6.1.4 Australia Plasma Therapy Market Revenues & Volume, By Leukocyte-Rich PRP, 2021- 2031F |
6.1.5 Australia Plasma Therapy Market Revenues & Volume, By Pure Platelet-Rich Fibrin, 2021- 2031F |
6.1.6 Australia Plasma Therapy Market Revenues & Volume, By Leukocyte-Rich Fibrin, 2021- 2031F |
6.2 Australia Plasma Therapy Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Plasma Therapy Market Revenues & Volume, By Orthopedics, 2021- 2031F |
6.2.3 Australia Plasma Therapy Market Revenues & Volume, By Dermatology, 2021- 2031F |
6.2.4 Australia Plasma Therapy Market Revenues & Volume, By Dentistry, 2021- 2031F |
6.2.5 Australia Plasma Therapy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Plasma Therapy Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Australia Plasma Therapy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Australia Plasma Therapy Market Revenues & Volume, By Dermatology Clinics, 2021- 2031F |
6.3.4 Australia Plasma Therapy Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Plasma Therapy Market Import-Export Trade Statistics |
7.1 Australia Plasma Therapy Market Export to Major Countries |
7.2 Australia Plasma Therapy Market Imports from Major Countries |
8 Australia Plasma Therapy Market Key Performance Indicators |
8.1 Number of clinical trials utilizing plasma therapy in Australia |
8.2 Adoption rate of plasma therapy in different medical specialties |
8.3 Patient satisfaction and reported outcomes following plasma therapy treatments |
9 Australia Plasma Therapy Market - Opportunity Assessment |
9.1 Australia Plasma Therapy Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Plasma Therapy Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Australia Plasma Therapy Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Australia Plasma Therapy Market - Competitive Landscape |
10.1 Australia Plasma Therapy Market Revenue Share, By Companies, 2024 |
10.2 Australia Plasma Therapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |